Literature DB >> 10520894

Interferon plus ribavirin: a cautionary note.

G Macedo, T Ribeiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10520894     DOI： 10.1111/j.1572-0241.1999.03087.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

Review 1.  Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

Authors:  Mark S Sulkowski; Curtis Cooper; Bela Hunyady; Jidong Jia; Pavel Ogurtsov; Markus Peck-Radosavljevic; Mitchell L Shiffman; Cihan Yurdaydin; Olav Dalgard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

Review 2.  The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.

Authors:  Mohammed Ahmed Akkaif; Abubakar Sha'aban; Arturo Cesaro; Ammar Ali Saleh Jaber; Andrea Vergara; Ismaeel Yunusa; Abubakar Ibrahim Jatau; Mustapha Mohammed; G Saravana Govindasamy; Majed Ahmed Al-Mansoub; Muhamad Ali Sheikh Abdul Kader; Baharudin Ibrahim
Journal:  Inflammopharmacology       Date:  2022-06-14       Impact factor: 5.093

3.  Coronary plaque instability in severe acute respiratory syndrome.

Authors:  Kin-Lam Tsui; Tat-Chi Leung; Loretta Yin-Chun Yam; Loletta Kit-Ying So; Edwin Poon; Kwok-Cheung Lung; Shu-Kin Li
Journal:  Int J Cardiol       Date:  2005-03-30       Impact factor: 4.164
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.